NSEPress Release28 Aug 2026 · 28 Aug 2026, 05:15 pm

Press Release

Fischer Medical Ventures Limited · FISCHER

✦ AI Summary▲ PositiveProduct Launch

Fischer Medical Ventures Limited's wholly owned subsidiary, Time Medical International Ventures (India) Private Ltd., has launched the CLARION 64/128-Slice AI-Driven CT System in India at the India Health Expo 2026.

Analysis Scores

Earnings Impact2/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact6/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated August 28, 2026, titled "Time Medical International Ventures Launches Next-Generation CLARION 64/128-Slice AI-Driven CT System at India Health Expo 2026".

Attachments (1)

📄

FISCHER_28082026171509_Pressrelease280826.pdf

pdf

Download →
View document text
FISCHER MEDICAL VENTURES LIMITED Registered Office Address: Survey No. 480/2 AP Medtech Zone Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032 CIN: L86900AP1993PLC118162 Email: enquiry@fischermv.com | Website: www.fischermv.com | Contact 9080966548 August 28, 2026 To To BSE Limited National Stock Exchange of India Ltd. Corporate Relationship Department Exchange Plaza, 5tll floor 25th Floor, P J Towers Plot No. C/ 1, G Block, Dalal Street, Fort, Bandra-Kurla Complex Bandra (E), Mumbai – 400 001 Mumbai - 400 051 BSE Scrip Code: 524743 NSE Symbol: FISCHER Dear Sir/Madam, Reg : Press Release on Time Medical International Ventures Launches Next- Generation CLARION 64/128-Slice AI-Driven CT System at India Health Expo 2026 We enclose a press release regarding Time Medical International Ventures (India) Private Ltd. (TMIV Imaging), a wholly owned subsidiary of Fischer Medical Ventures Limited, marked an important milestone with the launch of the CLARION 64/128-Slice AI-Driven CT System in India for dissemination. Thanking you, Yours Truly, For FISCHER MEDICAL VENTURES LIMITED BALAJI GANDLA COMPANY SECRETARY & COMPLIANCE OFFICER Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006 CIN L86900AP1993PLC118162 Corporate : Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Office Tamil Nadu, 600006 Registered : No. 480/2 AP Medtech Zone, Nadupura Village, Pedagantyadu Mandal, Office Visakhapatnam, 530032 Time Medical International Ventures Launches Next-Generation CLARION 64/128-Slice AI- Driven CT System at India Health Expo 2026 Time Medical International Ventures (India) Private Ltd. (TMIV Imaging), a wholly owned subsidiary of Fischer Medical Ventures Limited, marked an important milestone with the launch of the CLARION 64/128-Slice AI-Driven CT System in India. The launch reinforces TMIV Imaging’s commitment to advancing intelligent, efficient and sustainable healthcare delivery by integrating advanced engineering, artificial intelligence and intelligent clinical workflows. The initiative marks another step towards strengthening India’s medical imaging ecosystem and enabling faster, precise, accessible and technology-enabled diagnostic care. Time Medical International Ventures (TMIV Imaging), a wholly owned subsidiary of Fischer Medical Ventures Limited, marked an important milestone in advancing medical imaging technology in India with the launch of its CLARION 64/128-Slice High-Performance AI-Driven CT System at the India Health Expo 2026. The system was formally launched by Dr. Sunil K. Khetrapal, Deputy Director General, Association of Healthcare Providers India (AHPI), in the presence of healthcare leaders, industry representatives, and stakeholders from across the sector. The launch reflects TMIV Imagings’s continued focus on bringing advanced, intelligent, and clinically relevant imaging technologies to the Indian healthcare ecosystem. The CLARION CT platform combines high-performance imaging hardware with AI-driven workflow capabilities to support greater diagnostic precision, operational efficiency, patient throughput, and reliability across a broad spectrum of clinical applications. At the heart of the system is an advanced Liquid Metal Bearing (LMB) X-ray tube with 360° liquid metal cooling, designed for superior heat dissipation, stable focal spot positioning, continuous high- speed operation, and extended tube life. Its Aegis Detector System is engineered to enhance image clarity and low-contrast detectability while supporting low-dose imaging protocols. The platform further incorporates intelligent workflow capabilities including three-click scanning, AI-assisted automatic patient positioning using a quad-lens depth camera, and remote-control functionality, helping simplify CT operations and improve workflow efficiency. Available in scalable configurations extending up to 128 slices, the CLARION platform addresses requirements ranging from routine diagnostic imaging to advanced cardiac, vascular, neurological, thoracic, abdominal, orthopaedic, and interventional applications. The 64-slice configuration with a 91 cm bore expands its suitability for vascular imaging as well as intraoperative applications, while the 128-slice configuration supports advanced clinical procedures requiring higher temporal resolution. Beyond conventional diagnostic imaging, CLARION has been designed to extend CT into the interventional and surgical environment. Its Big Bore CT-on-Rail configuration enables mobility between clinical scenarios and supports hybrid operating room integration, real-time surgical imaging, procedural guidance, and Angio CT integration with DSA. Advanced capabilities such as 4D CT phased acquisition can also support respiratory monitoring and improved tumor targeting during radiotherapy by helping reduce motion-related artifacts. The launch was graced by Dr. Sunil K. Khetrapal, a distinguished healthcare administrator and policy advocate with more than three decades of experience spanning hospital management, healthcare strategy, quality systems, institutional transformation, and patient safety. In his role as Deputy Director General of AHPI, Dr. Khetrapal has been closely associated with initiatives aimed at strengthening collaboration among healthcare providers, regulators, and other stakeholders while advancing quality, accreditation, digital adoption, and sustainable healthcare delivery across India. His presence at the launch was particularly significant as healthcare in India moves towards greater adoption of intelligent technologies that can strengthen diagnostic capacity while simultaneously addressing the need for efficiency, accessibility, quality, and patient safety. With the introduction of the CLARION 64/128-Slice AI-Driven CT System in India, TMIV Imaging reinforces its commitment to building a comprehensive medical imaging ecosystem that brings together advanced engineering, artificial intelligence, intelligent clinical workflows, and application- driven innovation. The launch represents another step towards enabling healthcare institutions to deliver faster, more precise, efficient, and technology-enabled diagnostic and interventional care across India. About Time Medical International Ventures (India) Private Limited Time Medical International Ventures (India) Private Limited is a global leader in advanced medical imaging solutions and a wholly owned subsidiary of Fischer Medical Ventures Limited. Headquartered in Chennai, Time Medical India specializes in the design and manufacture of high-performance, cost-effective MRI systems that democratize access to advanced diagnostic imaging across emerging and developed markets alike. For further information, please contact: Fischer Medical Ventures Limited Email: enquiry@fischermv.com Website: www.fischermv.com Contact: 9080966548 Disclaimer: This investor release is not an offer to sell any securities or a solicitation to buy any securities of Fischer Medical Ventures Limited (the "company") or its subsidiaries (together with the company, the "group"). Certain statements in this document may be forward looking statements. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", " estimates"," anticipates", " projects", " expects", " intends", " may", " will"," or " or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, aims, objectives, goals, future events or intention. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local political or economic developments, technological risks, and many other factors that could cause our actual results to differ materially from those contemplated by the relevant forward-looking statements. Forward looking statements are not guarantees of future performance including those rel [Showing first 8,000 characters — download PDF for full document]